Short answer
West Pharmaceutical Services (WST) filed an 8-K current report with the SEC on May 11, 2026 reporting Item 1.05 (Material Cybersecurity Incidents), Item 7.01 (Regulation FD Disclosure). Material cyberattack confirmed May 7, following initial detection May 4.
- This filing includes Item 1.05, an item that often signal trouble.
West Pharmaceutical Services 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.05 · Material Cybersecurity Incidents
- Material cyberattack confirmed May 7, following initial detection May 4
- Unauthorized data exfiltration and system encryption create potential privacy, remediation, and legal exposure
- Global operations temporarily disrupted; shipping, receiving, and manufacturing restarting unevenly
- Core enterprise systems restored, but complete recovery timeline remains unresolved
- Financial impact on results and condition remains undetermined, creating near-term earnings uncertainty
Item 7.01 · Regulation FD Disclosure
- Company website statement furnished as Exhibit 99.1 under Regulation FD
- Investor-relevant disclosure requires reviewing Exhibit 99.1 for the underlying matter
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other West Pharmaceutical Services 8-K filings
Get the next WST 8-K as it lands
Follow WST for push alerts, or ask the research agent what this filing means.